MAP2K7 and head and neck squamous cell carcinoma: Interestingly, we did not find overlapping sensitivities (Fig. 1D; Supplementary Fig. S2A), which suggested to us that SHP099 may inhibit additional oncogenic pathways in sensitive HNSCC cell lines outside the MEK/ERK pathway.